Thiel-Behnke corneal dystrophy
MONDO:0011185Thiel-Behnke corneal dystrophy (TBCD) is a rare form of superficial corneal dystrophy characterized by sub-epithelial honeycomb-shaped corneal opacities in the superficial cornea, and progressive visual impairment.
Also known as: TBCD, Thiel-Behnke corneal dystrophy, Waardenburg-Jonker corneal dystrophy, anterior limiting membrane dystrophy type 2, anterior limiting membrane dystrophy type II, corneal dystrophy of Bowman layer type 2, corneal dystrophy of Bowman layer type II, curly fiber corneal dystrophy
8 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Can a single Gene-Editing injection stop a blinding corneal disease?
⭐️ CURE ⭐️ Not yet recruitingThis trial tests a single injection of GEB-101, a gene-editing treatment, directly into the cornea of people with TGFBI-related corneal dystrophy, a hereditary condition that causes progressive vision loss. The study aims to see if the treatment is safe and whether it can slow or…
Phase: PHASE1, PHASE2 • Sponsor: GenEditBio Limited • Aim: ⭐️ CURE ⭐️
Last updated Aug 08, 2026 00:03 UTC
-
New eye test spots brain fog after cornea surgery
Diagnosis Not yet recruitingThis study checks if a special thinking test (MoCA Blind) can find memory or thinking problems after cornea surgery. It includes 200 adults with cornea disease who will take the test before and 90 days after surgery. The goal is to give doctors a better way to spot these issues i…
Sponsor: The S.N. Fyodorov Eye Microsurgery State Institution • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC